Evidence map›Paper›PMID 40125508›Full record

ArticleWorld journal of gastrointestinal endoscopy2025

Efficacy and applications for PuraStat

Raquel Ballester, Conor Costigan, Aoife Mary O'Sullivan, Shreyashee Sengupta, Deirdre McNamara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Hemostasis: Role of PuraStatWorld journal of gastrointestinal endoscopy · 2025
    Article
  2. Article
  3. Narrative Review of Management Strategies and Risk Mitigation for Gastrointestinal Bleeding in Atrial Fibrillation Patients Receiving Warfarin.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Raquel BallesterDepartment of Gastroenterology, Tallaght University Hospital, Dublin D24, Ireland.
Conor CostiganDepartment of Gastroenterology, Tallaght University Hospital, Dublin D24, Ireland.
Aoife Mary O'SullivanDepartment of Gastroenterology, Tallaght University Hospital, Dublin D24, Ireland.
Shreyashee SenguptaDepartment of Gastroenterology, Tallaght University Hospital, Dublin D24, Ireland.
Deirdre McNamaraDepartment of Gastroenterology, Tallaght University Hospital, Dublin D24, Ireland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemostatic powders have been used as primary or salvage therapy to control gastrointestinal bleeding in a number of scenarios. PuraStat

aimTo evaluate PuraStat

methodsWe performed a retrospective single-centre analysis of all consecutive patients with gastrointestinal bleeding, that required endoscopic treatment and where PuraStat

resultsIn total 45 patients were included, and 17/45 (37.8%) females. The mean age was 65.8 years. Charlson score was > 2 in 27/45 (60%) and 26/45 (57.8%) required transfusion. The procedures were gastroscopy (77.8%), colonoscopy (15.5%), endoscopic retrograde cholangiopancreatography (4.4%) and enteroscopy (2.2%). The most common bleeding lesion was peptic ulcer (33.3%). PuraStat

conclusionPuraStat

Indexed as

Endoscopic hemostasisEndoscopic hemostatic agentGastrointestinal hemorrageHemostatic gelHemostatic techniquesPuraStat®

Identifiers

PMID40125508
PMCPMC11923975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.